LAM Pharmaceutical, Corp. a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced that Ixora Bio Medical Company Inc., a licensee of LAM, is poised to commence marketing and commercial sales of “Ixora for Women”, a non-prescription female sexual enhancement product Ixora has licensed from LAM.

John Easton, chief executive officer of Ixora Bio Medical, stated, “The impending launch of “Ixora for Women” represents a major milestone for us. It is the culmination of four years of extensive research and development, clinical studies and marketing research. “Ixora for Women” is the first of several products addressing sexual dysfunction in both men and women based on LAM IPM Ionic Polymer Matrix platform that Ixora has licensed from LAM. It will be marketed and sold as a sophisticated, upscale sexual enhancement product, addressing the difficulties associated with female sexual function disorders. The Journal of the American Medical Association has recently stated that 43.0 per cent of American women have faced at least one sexual function issue. These statistics are based on a national sampling of women ages 18-59.” Mr. Easton added, “In preparation for the launch, Ixora has assembled a group of first class professionals including a medical advisory board as well as branding, marketing and public relations teams. Ixora Bio Medical has established a network of sales outlets throughout North America for its “Ixora for Women” and has contracted manufacturing to a leading New Jersey based FDA approved GMP manufacturing facility.”

Joseph Slechta, president and chief executive officer of LAM, remarked, “We are very pleased about our licensee’s achievement. Ixora has had our total support throughout the commercialization stage. We will work with Ixora’s marketing team to ensure the successful launch of its first product. LAM anticipates royalty revenues from “Ixora for Women” to commence in the first half of 2004.”Mr. Slechta concluded, “The upcoming launch of “Ixora for Women” is particularly timely. The subject of human sexuality has come to the forefront in recent years and we are proud that Ixora has the opportunity to make a major positive contribution to this field.”